Sign inJoin waitlistJoin the waitlist

Christopher Dittus

Emergency Medicine · Unc Physicians and Associates

Credentials: · · · ·

History

Hematology and Medical Oncology
University of North Carolina Hospitals
2012–2015
University of North Carolina Hospitals
2009–2012
New York Institute of Technology College of Osteopathic Medicine
2005–2009

Research

Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type
Archives of Pathology & Laboratory Medicine · 2004 · 335 citations
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Journal of Clinical Oncology · 2020 · 318 citations
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma
Blood · 2019 · 72 citations

Natalie Grover
14 papers
Anne Beaven
12 papers
Steven Park
6 papers
Jonathan Serody
4 papers
Paul Rubinstein
4 papers
Robert Baiocchi
4 papers
TV
Timothy Voorhees
4 papers · 2 as a fellow
Jorge Castillo
3 papers
Jose Sandoval-Sus
3 papers
Mark Sloan
3 papers
Tatyana Feldman
3 papers
TS
Thomas Shea
3 papers

Clinical trials

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Principal investigator · Terminated · Phase 2
UNC Lineberger Comprehensive Cancer Center
2023–2025
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
Principal investigator · Active not recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
2020–2030
Epcoritamab in Previously Treated WM
Site PI · Recruiting · Phase 2
Gottfried von Keudell, MD PhD
2024–2027
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Site PI · Recruiting · Early phase 1
AIDS Malignancy Consortium
2021–2030